Advertisement

Rare Fungal Infections in Asia

  • Ariya Chindamporn
  • Navaporn Worasilchai
Chapter
First Online:

Abstract

The etiologic agents, underlying diseases, the disease spectrum, the successful treatment of rare infections from true fungi and fungal-like microbes in Asian countries including the surveillance data of minimum inhibitory concentrations were summarized.

Keywords

Rare fungal infections Mucormycosis Yeasts Mold Asia Pythium insidiosum Entomopththoromycosis Rhinosporidiosis 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Chander J, Singla N, Kaur M, Punia RS, Attri A, Alastruey-Izquierdo A, et al. Saksenaea erythrospora, an emerging mucoralean fungus causing severe necrotizing skin and soft tissue infections—a study from a tertiary care hospital in north India. Infect Dis (Lond). 2017;49(3):170–7.CrossRefGoogle Scholar
  2. 2.
    Skiada A, Pavleas I, Drogari-Apiranthitou M. Rare fungal infectious agents: a lurking enemy. F1000Res. 2017;6:1917.PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    Tap RM, Ramli NY, Sabaratnam P, Hashim R, Bakri AR, Bee LB, et al. First two cases of fungal infections associated with multi-drug resistant yeast, Fereydounia khargensis. Mycopathologia. 2016;181(7–8):531–7.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Jung J, Moon YS, Yoo JA, Lim JH, Jeong J, Jun JB. Investigation of a nosocomial outbreak of fungemia caused by Candida pelliculosa (Pichia anomala) in a Korean tertiary care center. J Microbiol Immunol Infect. 2018;51(6):794–801.PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Chakrabarti A, Singh K, Narang A, Singhi S, Batra R, Rao KL, et al. Outbreak of Pichia anomala infection in the pediatric service of a tertiary-care center in Northern India. J Clin Microbiol. 2001;39(5):1702–6.PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Wu Y, Wang J, Li W, Jia H, Che J, Lu J, et al. Pichia fabianii blood infection in a premature infant in China: case report. BMC Res Notes. 2013;6:77.PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    Shang ST, Lin JC, Ho SJ, Yang YS, Chang FY, Wang NC. The emerging life-threatening opportunistic fungal pathogen Kodamaea ohmeri: optimal treatment and literature review. J Microbiol Immunol Infect. 2010;43(3):200–6.PubMedCrossRefPubMedCentralGoogle Scholar
  8. 8.
    de Almeida Junior JN, Hennequin C. Invasive Trichosporon infection: a systematic review on a re-emerging fungal pathogen. Front Microbiol. 2016;7:1629.PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Davies GE, Thornton CR. Differentiation of the emerging human pathogens Trichosporon asahii and Trichosporon asteroides from other pathogenic yeasts and moulds by using species-specific monoclonal antibodies. PLoS One. 2014;9(1):e84789.PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Al-Mahmeed M, Khan ZU, Ahmad S, Chehadeh W. Antifungal susceptibility profile of clinical Trichosporon asahii and Trichosporon asteroides isolates identified by molecular methods. J Chemother. 2009;21(3):360–2.PubMedCrossRefGoogle Scholar
  11. 11.
    Lemes RM, Lyon JP, Moreira LM, de Resende MA. Antifungal susceptibility profile of Trichosporon isolates: correlation between CLSI and etest methodologies. Braz J Microbiol. 2010;41(2):310–5.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Mitomo H, Sakurada A, Matsuda Y, Notsuda H, Watanabe T, Oishi H, et al. Endobronchial topical amphotericin B instillation for pulmonary chromomycosis after lung transplantation: a case report. Transplant Proc. 2018;50(3):939–42.PubMedCrossRefGoogle Scholar
  13. 13.
    Navanukroh O, Jitmuang A, Chayakulkeeree M, Ngamskulrungroj P. Disseminated Cunninghamella bertholletiae infection with spinal epidural abscess in a kidney transplant patient: case report and literature review. Transpl Infect Dis. 2014;16(4):658–65.PubMedCrossRefGoogle Scholar
  14. 14.
    Su YY, Chang TY, Wang CJ, Jaing TH, Hsueh C, Chiu CH, et al. Disseminated Cunninghamella bertholletiae infection during induction chemotherapy in a girl with high-risk acute lymphoblastic leukemia. Pediatr Neonatol. 2016;57(6):531–4.PubMedCrossRefGoogle Scholar
  15. 15.
    Varshney S, Gupta P, Bist SS, Bhagat S. Conidiobolus coronatus granuloma of the right inferior turbinate: a rare presentation. Ear Nose Throat J. 2015;94(4–5):E32–5.PubMedGoogle Scholar
  16. 16.
    Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54(Suppl 1):S23–34.CrossRefGoogle Scholar
  17. 17.
    Gupta E, Verma U, Lal P, Gupta PC, Prakash P. Post tooth extraction necrotising fasciitis and rhinocerebral mucormycosis in a diabetic patient. Int J Curr Microbiol Appl Sci. 2018;7(7).CrossRefGoogle Scholar
  18. 18.
    Worasilchai N, Permpalung N, Chongsathidkiet P, Leelahavanichkul A, Mendoza AL, Palaga T, et al. Monitoring anti-pythium insidiosum IgG antibodies and (1-->3)-beta-d-glucan in vascular pythiosis. J Clin Microbiol. 2018;56(8).Google Scholar
  19. 19.
    Agarwal S, Iyer G, Srinivasan B, Agarwal M, Panchalam Sampath Kumar S, Therese LK. Clinical profile of pythium keratitis: perioperative measures to reduce risk of recurrence. Br J Ophthalmol. 2018;102(2):153–7.PubMedCrossRefGoogle Scholar
  20. 20.
    He H, Liu H, Chen X, Wu J, He M, Zhong X. Diagnosis and treatment of pythium insidiosum corneal ulcer in a chinese child: a case report and literature review. Am J Case Rep. 2016;17:982–8.PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Rathi A, Chakrabarti A, Agarwal T, Pushker N, Patil M, Kamble H, et al. Pythium keratitis leading to fatal cavernous sinus thrombophlebitis. Cornea. 2018;37(4):519–22.PubMedCrossRefGoogle Scholar
  22. 22.
    Chindamporn A, Chakrabarti A, Li R, Sun PL, Tan BH, Chua M, et al. Survey of laboratory practices for diagnosis of fungal infection in seven Asian countries: an Asia Fungal Working Group (AFWG) initiative. Med Mycol. 2018;56(4):416–25.PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Janagond A, Krishnan KM, Kindo AJ, Sumathi G. Trichosporon inkin, an unusual agent of fungal sinusitis: a report from south India. Indian J Med Microbiol. 2012;30(2):229–32.PubMedCrossRefGoogle Scholar
  24. 24.
    Tendolkar U, Shinde A, Baveja S, Dhurat R, Phiske M. Trichosporon inkin and Trichosporon mucoides as unusual causes of white piedra of scalp hair. Indian J Dermatol Venereol Leprol. 2014;80(4):324–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Xiaoxi X, Yaling D, Kaiwen Z, Xin R, Pradhan S, Yuping R. Trichosporon inkin causing subcutaneous sinus tract: Successfully treated by oral and ultrasound-guided intralesional itraconazole therapy. Indian J Dermatol Venereol Leprol. 2017;83(4):506–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Duggal S, Jain H, Tyagi A, Sharma A, Chugh TD. Rhodotorula fungemia: two cases and a brief review. Med Mycol. 2011;49(8):879–82.PubMedGoogle Scholar
  27. 27.
    Roy U, Jessani LG, Rudramurthy SM, Gopalakrishnan R, Dutta S, Chakravarty C, et al. Seven cases of Saccharomyces fungaemia related to use of probiotics. Mycoses. 2017;60(6):375–80.PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Sipsas N, Kontoyiannis DP. Trichosporon species and Blastoschizomyces capitatus. 2010.Google Scholar
  29. 29.
    Gao GX, Tang HL, Zhang X, Xin XL, Feng J, Chen XQ. Invasive fungal infection caused by geotrichum capitatum in patients with acute lymphoblastic leukemia: a case study and literature review. Int J Clin Exp Med. 2015;8(8):14228–35.PubMedPubMedCentralGoogle Scholar
  30. 30.
    Brunetti G, Visconti V, Ghezzi MC, Mantovani S, Ferretti G, Raponi G. Management and treatment of Magnusiomyces capitatus (Geotrichum capitatum) pleural infection in a non-neutropenic patient with posaconazole. A new therapeutic opportunity? New Microbiol. 2016;39(4):307–9.PubMedPubMedCentralGoogle Scholar
  31. 31.
    Subramanya Supram H, Gokhale S, Chakrabarti A, Rudramurthy SM, Gupta S, Honnavar P. Emergence of Magnusiomyces capitatus infections in Western Nepal. Med Mycol. 2016;54(2):103–10.PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Hsiao CH, Yeh LK, Chen HC, Lin HC, Chen PY, Ma DH, et al. Clinical characteristics of alternaria keratitis. J Ophthalmol. 2014;2014:536985.PubMedPubMedCentralGoogle Scholar
  33. 33.
    Chhabra V, Rastogi S, Barua M, Kumar S. Alternaria alternata infection associated osteomyelitis of maxilla: a rare disease entity. Indian J Dent Res. 2013;24(5):639–41.PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Chowdhary A, Agarwal K, Randhawa HS, Kathuria S, Gaur SN, Najafzadeh MJ, et al. A rare case of allergic bronchopulmonary mycosis caused by Alternaria alternata. Med Mycol. 2012;50(8):890–6.PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    Mirhendi H, Fatemi MJ, Bateni H, Hajabdolbaghi M, Geramishoar M, Ahmadi B, et al. First case of disseminated phaeohyphomycosis in an immunocompetent individual due to Alternaria malorum. Med Mycol. 2013;51(2):196–202.PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Mohd Tap R, Sabaratnam P, Ahmad NA, Abd Razak MF, Hashim R, Ahmad N. Chaetomium globosum cutaneous fungal infection confirmed by molecular identification: a case report from Malaysia. Mycopathologia. 2015;180(1–2):137–41.PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    Kuboi T, Okazaki K, Inotani M, Sugino M, Sadamura T, Nakano A, et al. A case of cutaneous Paecilomyces formosus infection in an extremely premature infant. J Infect Chemother. 2016;22(5):339–41.PubMedCrossRefPubMedCentralGoogle Scholar
  38. 38.
    Sharma S, Capoor MR, Singh M, Kiran D, Mandal AK. Subcutaneous phaeohyphomycosis caused by pyrenochaeta romeroi in a rheumatoid arthritis patient: a case report with review of the literature. Mycopathologia. 2016;181(9–10):735–43.PubMedCrossRefGoogle Scholar
  39. 39.
    Kim CM, Lim SC, Kim J, Jang HS, Chung JH, Yun NR, et al. Tenosynovitis caused by Scedosporium apiospermum infection misdiagnosed as an Alternaria species: a case report. BMC Infect Dis. 2017;17(1):72.PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Rynga D, Capoor MR, Varshney S, Naik M, Gupta V. Scedosporium apiospermum, an emerging pathogen in India: case series and review of literature. Indian J Pathol Microbiol. 2017;60(4):550–5.PubMedCrossRefGoogle Scholar
  41. 41.
    Ishii S, Hiruma M, Hayakawa Y, Sugita T, Makimura K, Hiruma M, et al. Cutaneous Pseudallescheria boydii/Scedosporium apiospermum complex (molecular type: Scedosporium apiospermum [Clade 4]) infection: a case report and literature review of cases from Japan. Med Mycol J. 2015;56(4):E25–30.PubMedCrossRefGoogle Scholar
  42. 42.
    Fadzillah MT, Ishak SR, Ibrahim M. Refractory Scedosporium apiospermum keratitis successfully treated with combination of amphotericin B and voriconazole. Case Rep Ophthalmol Med. 2013;2013:413953.PubMedPubMedCentralGoogle Scholar
  43. 43.
    Yoon S, Kim S, Lee KA, Kim H. [A case of Scedosporium apiospermum keratitis confirmed by a molecular genetic method]. Korean J Lab Med. 2008;28(4):307–11.PubMedCrossRefGoogle Scholar
  44. 44.
    Pastor FJ, Guarro J. Alternaria infections: laboratory diagnosis and relevant clinical features. Clin Microbiol Infect. 2008;14(8):734–46.PubMedCrossRefGoogle Scholar
  45. 45.
    Borman AM, Fraser M, Palmer MD, Szekely A, Houldsworth M, Patterson Z, et al. MIC distributions and evaluation of fungicidal activity for amphotericin B, itraconazole, voriconazole, posaconazole and caspofungin and 20 species of pathogenic filamentous fungi determined using the CLSI broth microdilution method. J Fungi (Basel). 2017;3(2).Google Scholar
  46. 46.
    Serena C, Ortoneda M, Capilla J, Pastor FJ, Sutton DA, Rinaldi MG, et al. In vitro activities of new antifungal agents against Chaetomium spp. and inoculum standardization. Antimicrob Agents Chemother. 2003;47(10):3161–4.PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Katragkou A, Pana ZD, Perlin DS, Kontoyiannis DP, Walsh TJ, Roilides E. Exserohilum infections: review of 48 cases before the 2012 United States outbreak. Med Mycol. 2014;52(4):376–86.PubMedCrossRefGoogle Scholar
  48. 48.
    Castelli MV, Alastruey-Izquierdo A, Cuesta I, Monzon A, Mellado E, Rodriguez-Tudela JL, et al. Susceptibility testing and molecular classification of Paecilomyces spp. Antimicrob Agents Chemother. 2008;52(8):2926–8.PubMedPubMedCentralCrossRefGoogle Scholar
  49. 49.
    Badali H, Chander J, Gulati N, Attri A, Chopra R, Najafzadeh MJ, et al. Subcutaneous phaeohyphomycotic cyst caused by Pyrenochaeta romeroi. Med Mycol. 2010;48(5):763–8.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Lackner M, de Hoog GS, Verweij PE, Najafzadeh MJ, Curfs-Breuker I, Klaassen CH, et al. Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species. Antimicrob Agents Chemother. 2012;56(5):2635–42.PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Bhalla S, Srivastava VK, Gupta RK. Rhinofacial entomophthoramycosis: a rare fungal infection in an adolescent boy. Indian J Pathol Microbiol. 2015;58(3):402–3.PubMedCrossRefGoogle Scholar
  52. 52.
    Hirano T, Yamada M, Sato K, Murakami K, Tamai T, Mitsuhashi Y, et al. Invasive pulmonary mucormycosis: rare presentation with pulmonary eosinophilia. BMC Pulm Med. 2017;17(1):76.PubMedPubMedCentralCrossRefGoogle Scholar
  53. 53.
    Kimura M, Yaguchi T, Sutton DA, Fothergill AW, Thompson EH, Wickes BL. Disseminated human conidiobolomycosis due to Conidiobolus lamprauges. J Clin Microbiol. 2011;49(2):752–6.PubMedPubMedCentralCrossRefGoogle Scholar
  54. 54.
    Ota H, Yamamoto H, Kimura M, Araoka H, Fujii T, Umeyama T, et al. Successful treatment of pulmonary mucormycosis caused by Cunninghamella bertholletiae with high-dose liposomal amphotericin B (10 mg/kg/day) followed by a lobectomy in cord blood transplant recipients. Mycopathologia. 2017;182(9–10):847–53.PubMedCrossRefGoogle Scholar
  55. 55.
    Wang SB, Li RY, Yu J. Identification and susceptibility of Rhizomucor spp. isolated from patients with cutaneous zygomycosis in China. Med Mycol. 2011;49(8):799–805.PubMedGoogle Scholar
  56. 56.
    Gomez-Lopez A, Cuenca-Estrella M, Monzon A, Rodriguez-Tudela JL. In vitro susceptibility of clinical isolates of Zygomycota to amphotericin B, flucytosine, itraconazole and voriconazole. J Antimicrob Chemother. 2001;48(6):919–21.PubMedCrossRefGoogle Scholar
  57. 57.
    Reinprayoon U, Permpalung N, Kasetsuwan N, Plongla R, Mendoza L, Chindamporn A. Lagenidium sp. ocular infection mimicking ocular pythiosis. J Clin Microbiol. 2013;51(8):2778–80.PubMedPubMedCentralCrossRefGoogle Scholar
  58. 58.
    Kim JE, Oh TH, Lee KH, Shin JH, Jung SI. Successful treatment of protothecal tenosynovitis in an immunocompetent patient using amphotericin B deoxycholate. Infect Chemother. 2017;49(4):293–6.PubMedPubMedCentralCrossRefGoogle Scholar
  59. 59.
    Wang F, Feng P, Lin Y, Chen X, Xu D, Wang Z, et al. Human cutaneous protothecosis: a case report and review of cases from Mainland China, Hong Kong, and Taiwan. Mycopathologia. 2018;183(5):821–8.PubMedCrossRefGoogle Scholar
  60. 60.
    Permpalung N, Worasilchai N, Plongla R, Upala S, Sanguankeo A, Paitoonpong L, et al. Treatment outcomes of surgery, antifungal therapy and immunotherapy in ocular and vascular human pythiosis: a retrospective study of 18 patients. J Antimicrob Chemother. 2015;70(6):1885–92.PubMedGoogle Scholar
  61. 61.
    Das S, Kashyap B, Barua M, Gupta N, Saha R, Vaid L, et al. Nasal rhinosporidiosis in humans: new interpretations and a review of the literature of this enigmatic disease. Med Mycol. 2011;49(3):311–5.PubMedCrossRefGoogle Scholar
  62. 62.
    Narayana Kurup JK, Singasani R, Mohanty SP. Rare case of disseminated rhinosporidiosis with chronic osteomyelitis of the calcaneum treated by a simple technique of negative pressure wound therapy. BMJ Case Rep. 2017;2017.Google Scholar
  63. 63.
    Kaushal S, Mathur SR, Mallick SR, Ramam M. Disseminated cutaneous, laryngeal, nasopharyngeal, and recurrent obstructive nasal rhinosporidiosis in an immunocompetent adult: a case report and review of literature. Int J Dermatol. 2011;50(3):340–2.PubMedCrossRefGoogle Scholar
  64. 64.
    Kalamkar C, Mukherjee A. Bilateral conjunctival rhinosporidiosis in a paediatric patient. J Clin Diagn Res. 2017;11(9):NL01–NL2.PubMedPubMedCentralGoogle Scholar
  65. 65.
    Ahn A, Choe YJ, Chang J, Kim D, Sung H, Kim MN, et al. Chronic eosinophilic meningoencephalitis by Prototheca wickerhamii in an immunocompetent boy. Pediatr Infect Dis J. 2017;36(7):687–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  • Ariya Chindamporn
    • 1
  • Navaporn Worasilchai
    • 1
  1. 1.Mycology Unit, Department of Microbiology, Faculty of MedicineChulalongkorn UniversityBangkokThailand

Personalised recommendations

Cite chapter

Buy options